LYRA: Lyra Therapeutics, Inc Kompaniya qiymatining sof foydaga nisbati

Lyra Therapeutics Inc. (LYRA) korporativ emblemasi va logotipi

Lyra Therapeutics, Inc. (LYRA) faoliyati bozor sikllaridan mustaqildir, chunki ENT patologiyalari terapiyasiga bo'lgan talab YaIMdan qat'i nazar o'zgarmasdan qoladi. Biznes uzoq muddatli gormonal terapiyani almashtiruvchi innovatsion implant XTreo tomonidan ta'minlanadigan yuqori marjalarga tayanadi. 0.00 indikatori mavjud bo'lgan sahifadagi narxlar vizualizatsiyasi bioximiklarining barqaror shtati va komplayens mutaxassislarini maqsadli ishga olishga tegishli ma'lumotlarni to'ldiradi.

LYRA Lyra Therapeutics Inc: Narx-foyda koeffitsiyenti 04.07.2022 - 21.03.2026 oraligʻida

Lyra Therapeutics Inc. (LYRA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning har tomonlama tahlili:Lyra Therapeutics Inc. - LYRA
Lyra Therapeutics yetakchi tovari

ENT kasalliklarini davolash uchun biologik parchalanuvchi implantlarni ishlab chiquvchi Lyra Therapeutics, Inc. (LYRA) uchun ushbu koeffitsient innovatsion dori yetkazib berish tizimlarini tijoratlashtirishdan keladigan kelajakdagi foydalarning bozor qiymatini aks ettiradi. Kompaniyaga tegishli joriy aksiya narxi va aksiya uchun foyda koeffitsientining tarixiy P/E diapazoni orasidagi bog'liqlik aktivning haddan tashqari qimmat baholanganini yoki biznesning haqiqiy daromadliligiga nisbatan past baholanganini aniqlash imkonini beradi.

Raqobatdosh kompaniyalar tahlili

HLN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti KVUE (Kenvue Corp)|VRNA (Verona Pharma Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Jyong Biotech Limited MENS|Ligand (LGND) - Kapitalizatsiyaning foydaga nisbati|AMRX: Narx-foyda koeffitsiyenti|Perrigo - Bozor narxining sof foydaga nisbati|ALVO: P/E multiplikatori|Liquidia Technologies - Kompaniya qiymatining sof foydaga nisbati|GLPG (Galapagos N.V.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati anipharmaceuticals.com ANIP|Narxning foydaga nisbati MannKind (MNKD)|AMPH (Amphastar Pharmaceuticals, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Pacira BioSciences, Inc. PCRX|P/E multiplikatori ARS Corp SPRY|Theravance Biopharma - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Aquestive Therapeutics, Inc. (AQST)|scPharmaceuticals (SCPH) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Tectonic Therapeutic, Inc.|TNXP (Tonix Pharmaceuticals Holding) - P/E multiplikatori|Narx-foyda multiplikatori SXTC (China SXT Pharmaceuticals)|P/E multiplikatori EPRX|P/E multiplikatori bioharvest.com (BHST)|Narxning foydaga nisbati Invizyne Technologies EXOZ|ORMP: Narx-foyda multiplikatori|ENTX: Narx-foyda koeffitsiyenti|HYFT: Narxning foydaga nisbati|ABVC BioPharma Inc. (ABVC) - Narxning foydaga nisbati|cumberlandpharma.com (CPIX) - P/E multiplikatori|QNTM (Quantum BioPharma) - P/E multiplikatori|FGEN: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori TELO|P/E multiplikatori Rani Therapeutics Holdings (RANI)|P/E multiplikatori SNYR (Synergy CHC Corp)|Rallybio Corporation (RLYB) - Kapitalizatsiyaning foydaga nisbati|LEXX - Narxning foydaga nisbati|PULM (Pulmatrix) - Narx-foyda multiplikatori|Pheton Holdings Ltd (PTHL) - Narxning foydaga nisbati|Aptorum - Kompaniya qiymatining sof foydaga nisbati|IBO (impactbiomedinc.com) - P/E multiplikatori|TNFA (TNF Pharmaceuticals) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati cbdmd.com (YCBD)|Biznesning o‘zini qoplash muddati PainReform Ltd|P/E multiplikatori CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals (LIPO) - Kapitalizatsiyaning foydaga nisbati|OPTN - Narxning foydaga nisbati|Pieris Pharmaceuticals - Bozor narxining sof foydaga nisbati|PROC (Procaps Group) - Narx-foyda koeffitsiyenti|PTPI - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Qilian International Holding Group Limited|SLRN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti TFFP (TFF Pharma)